Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/2415
PMID: 23799855
DOI: 10.1038/bjc.2013.272
ISSN: 0007-0920
Services
Services
Date issued
2013Journal title
BRITISH JOURNAL OF CANCER
Type of content
Artigo
